Evidence map›Paper›PMID 35955819›Full record

ArticleInternational journal of molecular sciences2022

No-June Park, Beom-Geun Jo, Sim-Kyu Bong, Sang-A Park, Sullim Lee, Yong Kee Kim, Min Hye Yang, Su-Nam Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

No-June ParkNatural Products Research Institute, Korea Institute of Science and Technology (KIST), Gangneung 25451, Korea.
Beom-Geun JoCollege of Pharmacy, Pusan National University, Busan 46241, Korea.
Sim-Kyu BongNatural Products Research Institute, Korea Institute of Science and Technology (KIST), Gangneung 25451, Korea.
Sang-A ParkNatural Products Research Institute, Korea Institute of Science and Technology (KIST), Gangneung 25451, Korea.
Sullim LeeDepartment of Life Science, College of Bio-Nano Technology, Gachon University, Seongnam 13120, Korea.ORCID 0000-0002-4187-2177
Yong Kee KimCollege of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea.ORCID 0000-0002-6413-7538
Min Hye YangCollege of Pharmacy, Pusan National University, Busan 46241, Korea.
Su-Nam KimNatural Products Research Institute, Korea Institute of Science and Technology (KIST), Gangneung 25451, Korea.
Bio-Medical Science (South Korea) · KRKorea Institute of Science and Technology · KRPusan National University · KRGachon University · KRSookmyung Women's University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The skin acts as a mechanical barrier that protects the body from the exterior environment, and skin barrier function is attributed to the stratum corneum (SC), which is composed of keratinocytes and skin lipids. Skin barrier homeostasis is maintained by a delicate balance between the differentiation and exfoliation of keratinocytes, and keratinocyte desquamation is regulated by members of the serine protease kalikrein (KLK) family and their endogenous inhibitor SPINK5/LEKTI (serine protease inhibitor Kazal type 5/lympho-epithelial Kazal-type-related inhibitor). Furthermore, SPINK5/LEKTI deficiency is involved in impaired skin barrier function caused by KLK over-activation. We sought to determine whether increased SPINK5/LEKTI expression ameliorates atopic dermatitis (AD) by strengthening skin barrier function using the ethanol extract of

Indexed as

Dermatitis, AtopicLobeliaAnimalsDinitrochlorobenzeneFlavonoidsHumansMiceProteinase Inhibitory Proteins, SecretorySerine Peptidase Inhibitor Kazal-Type 5DinitrochlorobenzenediosmetinFlavonoidsProteinase Inhibitory Proteins, SecretorySerine Peptidase Inhibitor Kazal-Type 5SPINK5 protein, humanSpink5 protein, mouseatopic dermatitis (AD)diosmetinLobelia chinensisskin barrierSPINK5/LEKTI

Identifiers

PMID35955819
PMCPMC9369373
OpenAlexW4289856857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.